Oligonucleotide Synthesis Market Size, Status, Top Key Players, Trends Forecast And Future Aspect Analysis 2019–2025

The global oligonucleotide synthesis market is prophesied to benefit from late-stage clinical trials of a large number of oligos. Most of these trials are aimed at targeting different health problems including ocular disorders, muscle dystrophies, cardiovascular disease, and cancer. Business expansion through partnership with biotechnology and pharmaceutical companies is foreseen to help players to improve their presence in the global market. In July 2019, US biotechnology company supplying custom nucleic acids, Integrated DNA Technologies (IDT) entered into a multi-year supplier agreement with Clear Labs, a US private genomics testing company. IDT will supply next-generation sequencing (NGS) oligo products for Clear Labs’ NGS-based food safety platform, as part of the agreement.

Increasing Number of Ongoing Genetic Research Studies to Boost Demand

High application of oligonucleotide synthesis in a number of ongoing genetic researches is expected to drive the growth of the global market. Growing requirement of custom synthesis of various types of oligos such as immunostimulatory, aptamers, and decoys in sync with increasing genetic research investments is anticipated to create opportunities in the global oligonucleotide synthesis market. Growth in the requirement of custom-made nucleotides for desired sequence across forensic, drug development, genetic testing, and research applications could augur well for the global market. Other factors such as reducing cost of sequencing are predicted to strengthen the global market growth.

Get PDF template of this report: https://www.qyrconsulting.com/request-sample/7344

Players to Form Collaborations to Develop Innovative Products and Technologies

Some of the top companies operating in the global oligonucleotide synthesis market are Integrated DNA Technologies, Inc. (part of Danaher Corporation), Merck KGaA, Eurofins Scientific, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., GE Healthcare, GeneDesign, Inc. (part of Ajinomoto Co., Inc.), ATDBio Ltd., Kaneka Eurogentec (part of Kaneka Corporation), TriLink BioTechnologies, LLC (part of Maravai LifeSciences), Bio-synthesis Inc., and LGC Biosearch Technologies. Collaboration, distribution partnership, and acquisition are some of the important strategies that players could adopt in the coming years.

In July 2019, British synthetic biology firm, Evonetix announced in its press release that the company is taking a novel approach to gene synthesis. With a silicon, well-free chip-based system using heat to regulate chemical steps, the company is looking to design the future of DNA synthesis.

By Product

● Equipment

● Primer

● Reagent

● Probe

● Custom

● Linker

● Adaptor

By Application

● Therapeutic

● PCR

● Research

● RNAi

● DNA

By End User

● Biotechnology

● Academic

● Pharmaceutical

Among products, reagent is foreseen to exhibit significant growth in the global oligonucleotide synthesis market. Rising demand for specific types of reagent in key applications such as synthesis could support the market growth of this segment. Among applications, polymerase chain reaction (PCR) is foretold to become a prominent segment due to high use of PCR primers in target identification and screening during the development of drugs. Among end users, academic is forecast to secure a commanding market share because of increasing focus of academic research organizations on genomic research.

Get Complete Report in your Inbox within 24 hours: https://www.qyrconsulting.com/checkout/7344

Contact US
QYR Consulting
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 626 428 8800
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – sales@qyrconsulting.com
Web – https://www.qyrconsulting.com

About Us:
QYR Consulting established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

This release was published on openPR.